Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo

Oncogene volume 27, pages 339–346 (2008)Cite this article

Abstract

Δ9-Tetrahydrocannabinol (THC) is the primary cannabinoid of marijuana and has been shown to either potentiate or inhibit tumor growth, depending on the type of cancer and its pathogenesis. Little is known about the activity of cannabinoids like THC on epidermal growth factor receptor-overexpressing lung cancers, which are often highly aggressive and resistant to chemotherapy. In this study, we characterized the effects of THC on the EGF-induced growth and metastasis of human non-small cell lung cancer using the cell lines A549 and SW-1573 as in vitro models. We found that these cells express the cannabinoid receptors CB1 and CB2, known targets for THC action, and that THC inhibited EGF-induced growth, chemotaxis and chemoinvasion. Moreover, signaling studies indicated that THC may act by inhibiting the EGF-induced phosphorylation of ERK1/2, JNK1/2 and AKT. THC also induced the phosphorylation of focal adhesion kinase at tyrosine 397. Additionally, in in vivo studies in severe combined immunodeficient mice, there was significant inhibition of the subcutaneous tumor growth and lung metastasis of A549 cells in THC-treated animals as compared to vehicle-treated controls. Tumor samples from THC-treated animals revealed antiproliferative and antiangiogenic effects of THC. Our study suggests that cannabinoids like THC should be explored as novel therapeutic molecules in controlling the growth and metastasis of certain lung cancers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Adjei AA . (2006). Novel combinations based on epidermal growth factor receptor inhibition. Clin Cancer Res 12: 4446–4450.

    Article  Google Scholar 

  • Beckmann JD, Stewart A, Kai M, Keeton TP . (2001). Control of EGF-induced morphological transformation of human bronchial epithelial cells. J Cell Physiol 189: 171–178.

    Article  CAS  PubMed  Google Scholar 

  • Bifulco M, Laezza C, Pisanti S, Gazzerro P . (2006). Cannabinoids and cancer: pros and cons of an antitumour strategy. Br Jr Pharm 148: 123–135.

    Article  CAS  Google Scholar 

  • Blazquez C, Casanova ML, Planas A, Del Pulgar TG, Villanueva C, Fernandez-Acenero MJ et al. (2003). Inhibition of tumor angiogenesis by cannabinoids. FASEB J 17: 529–531.

    Article  CAS  PubMed  Google Scholar 

  • Bost F, McKay R, Dean N, Mercola D . (1997). The Jun kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. J Biol Chem 272: 33422–33429.

    Article  CAS  PubMed  Google Scholar 

  • Cabral GA, McNerney PJ, Mishkin EM . (1987). Interaction of delta-9-tetrahydrocannabinol with rat B103 neuroblastoma cells. Arch Toxicol 60: 439–449.

    Article  Google Scholar 

  • Caffarel MM, Sarrio D, Palacios J, Guzman M, Sanchez C . (2006). Δ9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. Cancer Res 66: 6615–6621.

    Article  CAS  PubMed  Google Scholar 

  • Carracedo A, Lorente M, Egia A, Blazquez C, Garcia S, Giroux V et al. (2006). Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Cell 9: 301–312.

    Article  CAS  PubMed  Google Scholar 

  • Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, Huffman JW et al. (2003). Inhibition of skin tumor growth and angiogenesis in-vivo by activation of cannabinoid receptors. J Clin Invest 111: 43–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Clarke N, Arenzana N, Hai T, Minden A, Prywes R . (1998). Epidermal growth factor induction of the c-jun promoter by a Rac pathway. Mol Cell Biol 21: 4016–4031.

    Google Scholar 

  • Derkinderen P, Toutant M, Kadare G, Ledent C, Parmentier M, Girault JA . (2001). Dual role of Fyn in the regulation of FAK+6, 7 by cannabinoids in hippocampus. J Biol Chem 276: 38289–38296.

    CAS  PubMed  Google Scholar 

  • Di Marzo V, Petrocellis LD . (2006). Plant, synthetic, and endogenous cannabinoids in medicine. Annu Rev Med 57: 553–574.

    Article  CAS  PubMed  Google Scholar 

  • Díaz-Laviada I, Ruiz-Llorente L . (2005). Signal transduction activated by cannabinoid receptors. Mini Rev Med Chem 5: 619–630.

    Article  PubMed  Google Scholar 

  • Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT et al. (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222–1226.

    Article  CAS  PubMed  Google Scholar 

  • Ghosh S, Preet A, Groopman JE, Ganju RK . (2006). Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes. Mol Immunol 43: 2169–2179.

    Article  CAS  PubMed  Google Scholar 

  • Guzmán M, Duarte MJ, Blázquez C, Ravina J, Rosa MC, Galve-Roperh I et al. (2006). A pilot clinical study of 9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br Jr Cancer 95: 204–209.

    Article  Google Scholar 

  • Hart S, Fischer OM, Ullrich A . (2004). Cannabinoids induce cancer cell proliferation via tumor necrosis factor {alpha}-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res 64: 1943–1950.

    Article  CAS  PubMed  Google Scholar 

  • Hauck CR, Sieg DJ, Hsia DA, Loftus JC, Gaarde WA, Monia BP et al. (2001). Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res 61: 7079–7090.

    CAS  PubMed  Google Scholar 

  • Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C et al. (2006). Cancer statistics. CA Cancer J Clin 56: 106–130.

    Article  PubMed  Google Scholar 

  • Kogan NM . (2005). Cannabinoids and cancer. Mini Rev Med Chem 5: 941–952.

    Article  CAS  PubMed  Google Scholar 

  • Li R, Wang H, Bekele BN, Yin Z, Caraway NP, Katz RL et al. (2005). Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. Oncogene 25: 2628–2635.

    Article  Google Scholar 

  • Lu Z, Jing G, Blume-Jensen P, Hunter T . (2001). Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol 21: 4016–4031.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI . (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. 346: 561–564.

  • McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC . (2005). The role of focal adhesion kinase in cancer: a new therapeutic opportunity. Nat Rev Cancer 5: 505–515.

    Article  CAS  PubMed  Google Scholar 

  • Mitra SK, Mikolon D, Molina JE, Hsia DA, Hanson DA, Chi A et al. (2006). Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors. Oncogene 25: 5969–5984.

    Article  CAS  PubMed  Google Scholar 

  • Molina JR, Adjei AA, Jett JR . (2006). Advances in chemotherapy of non-small cell lung cancer. Chest 130: 1211–1219.

    Article  CAS  PubMed  Google Scholar 

  • Munro S, Thomas KL, Abu-Shaar M . (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61–65.

    Article  CAS  PubMed  Google Scholar 

  • Munson AE, Harris LS, Friedman MA, Dewey WL, Carchman RA . (1975). Antineoplastic activity of cannabinoids. J Natl Cancer Inst (Bethesda) 55: 597–602.

    Article  CAS  Google Scholar 

  • Piomelli D . (2003). The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873–884.

    Article  CAS  PubMed  Google Scholar 

  • Salomon DS, Brandt R, Ciardiello F, Normanno N . (1995). Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19: 183–232.

    Article  CAS  PubMed  Google Scholar 

  • Sancho R, Calzado MA, Di Marzo V, Appendino G, Munoz E . (2003). Anandamide inhibits nuclear factor-kappa B activation through a cannabinoid receptor-independent pathway. Mol Pharmacol 63: 429–438.

    Article  CAS  PubMed  Google Scholar 

  • Schlessinger J . (2000). Cell signaling by receptor tyrosine kinases. Cell 103: 211–225.

    Article  CAS  PubMed  Google Scholar 

  • Ullrich A, Schlessinger J . (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203–212.

    Article  CAS  PubMed  Google Scholar 

  • Vaccani A, Massi P, Colombo A, Rubino T, Parolaro D . (2005). Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. Br J Pharmacol 144: 1032–1036.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Williams R, Sanghera J, Wu F, Carbonaro-Hall D, Campbell D, Warburton D et al. (1993). Identification of a human epidermal growth factor receptor-associated protein kinase as a new member of the mitogen-activated protein kinase/extracellular signal-regulated protein kinase family. J Biol Chem 268: 18213–18217.

    CAS  PubMed  Google Scholar 

  • Yarden Y, Sliwkowski MX . (2001). Untangling the Erbb signalling network. Nature Revs Mol Cell Bio 2: 127–137.

    Article  CAS  Google Scholar 

  • Yarden Y . (2001). The EGFR family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities. Eur J Cancer 37: S3–S8.

    Article  CAS  PubMed  Google Scholar 

  • Yujiri T, Ware M, Widmann C, Oyer R, Russell D, Chan E et al. (2000). MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation. Proc Natl Acad Sci USA 97: 7272–7277.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Justine Curley at the Histology Core Facility (BIDMC) for assistance with the immunohistochemistry and Janet Delahanty for editing this manuscript. This work was supported in part by NIH grant CA109527.

Author information

Author notes

  1. R K Ganju and J E Groopman: JEG and RKG share the senior and corresponding authorship.

Authors and Affiliations

  1. Division of Experimental Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

    A Preet, R K Ganju & J E Groopman

Authors
  1. A Preet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R K Ganju
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J E Groopman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to R K Ganju or J E Groopman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Preet, A., Ganju, R. & Groopman, J. Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene 27, 339–346 (2008). https://doi.org/10.1038/sj.onc.1210641

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210641

Keywords

This article is cited by

Search

Advanced search

Quick links